US Patent Issued to Redona Therapeutics on March 24 for "Benzo[hquinazolin-4-amine and thieno[3,2-hquinazolin-4-amine derivatives for the treatment of cancer" (Swiss Inventors)

ALEXANDRIA, Va., March 24 -- United States Patent no. 12,583,825, issued on March 24, was assigned to Redona Therapeutics Inc. (Watertown, Mass.).

"Benzo[hquinazolin-4-amine and thieno[3,2-hquinazolin-4-amine derivatives for the treatment of cancer" was invented by Sven Weiler (Allschwil, Switzerland), Berangere Gaucher (Allschwil, Switzerland), Florian Richalet (Allschwil, Switzerland), Stefan Reinelt (Allschwil, Switzerland), Thomas Radimerski (Allschwil, Switzerland) and Andrea Aloia (Allschwil, Switzerland).

According to the abstract* released by the U.S. Patent & Trademark Office: "The invention provides compounds of formula (IA) and compounds of formula (IB) and pharmaceutically acceptable salts thereof; wherein A is selected from g...